SCHEMBL5477186

SCHEMBL5477186

NC(=O)CN1C(=O)Cc2cc(OCF)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 6/20 0.38
ITGA2B P08514 6/20 0.38
PDE3B Q13370 2/20 0.37
PDE3A Q14432 2/20 0.37
CYP2C19 P33261 1/20 0.36
PDE4A P27815 3/20 0.35
PDE4B Q07343 3/20 0.35
PDE4C Q08493 3/20 0.35
PDE4D Q08499 3/20 0.35
BRD4 O60885 1/20 0.35
MAPT P10636 1/20 0.35
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34
PDK4 Q16654 1/20 0.34
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
P2RY12 Q9H244 1/20 0.33
HSD17B10 Q99714 2/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL661030 0.84 MAPT (0.47) MAPTPDK1PDK2PDK3PDK4
SCHEMBL29868564 0.84 MAPT (0.47) MAPTPDK1PDK2PDK3PDK4
SCHEMBL661264 0.80 PER2 (0.42) BRD4ALDH1A1GAATP53
SCHEMBL659938 0.77 BRD4 (0.36) CYP2C19BRD4ALDH1A1GAA
SCHEMBL661388 0.77 HDAC1 (0.44) MAPT
SCHEMBL661918 0.77 PDE5A (0.50) CYP2C19BRD4MAPTALDH1A1GAA
SCHEMBL664077 0.77 HDAC1 (0.44) BRD4MAPTALDH1A1GAAHSD17B10
SCHEMBL662015 0.76 ATM (0.46) CYP2C19MAPTALDH1A1
SCHEMBL29868554 0.76 ATM (0.46) CYP2C19MAPTALDH1A1
SCHEMBL660763 0.75 BRD4 (0.40) BRD4MAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043038-A1 Indolone-acetamide derivatives, processes for preparing them and their uses UCB, S.A. (BE) 2007-02-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043038-A1 Indolone-acetamide derivatives, processes for preparing them and their uses AANAT, TPH2, CYP1A2 ITGB3 4186/4885ITGA2B 3844/4885PDE3B 556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.